Vinmec Central Park Performs Vietnam's First SEEG using AutoGuide Robotic Guidance System for a child diagnosed from refractory epilepsy
This marks the first time in Vietnam that robotic guidance has been used in pediatric epilepsy surgery, — a milestone that opens new possibilities for safer, less invasive, and highly precise treatment options for vulnerable patients. The case also highlights Vietnam's progress in approaching global standards in advanced epilepsy care.
A 5-Year Search for Seizure-Free Sleep
The patient, B.Q.K. (age 9, from Hanoi), began experiencing seizures in 2021. Despite various treatment regimens and adjustments both domestically and abroad, his condition failed to improve - sometimes experiencing dozens of seizures per day.
For nearly five years, his family sought treatment at numerous medical centers in the hope of giving their child a peaceful night's sleep without seizures.
According to the World Health Organization (WHO), approximately 30% of epilepsy patients are drug-resistant (1), meaning they do not respond to medication. For these patients, surgery resection of the epileptic zone is often the most effective option. However, accurately localizing the epileptogenic zone - especially in children - is extremely challenging when scalp EEG, MRI, or PET scans provide inconclusive findings.
SEEG and AutoGuide: A Technological Duo to Precisely Locate the "Culprit" in the Brain
Following a thorough multidisciplinary evaluation, doctors at Vinmec Central Park decided to use AutoGuide™ robotic navigation system to perform stereo-electroencephalography (SEEG) to accurately identify the epileptic zone. The robotic guidance ensured high accuracy, faster operative time, and reduced trauma to the brain.
After seven days of SEEG monitoring, the epileptogenic zone was localized in the right orbitofrontal cortex and inferior frontal gyrus—areas densely packed with neural pathways and blood vessels. On June 17, 2025, the epileptic zone removal was performed by Dr. Truong Van Tri and his team at Vinmec Central Park, with technical support from Assoc. Prof. Dr. Shunsuke Nakae, an epilepsy specialist from Japan.
The surgery was successful, with no postoperative neurological deficits. After more than one month of recovery, the patient resumed normal activities and play, with only two minor nocturnal seizures recorded - a reduction of over 95% compared to preoperative frequency.
"For the first time, we achieved near-perfect outcome in pediatric epilepsy surgery thanks to AutoGuide™. This is a critical milestone, especially for young patients who are highly vulnerable to major brain surgery," said Dr. Tri.
Vinmec: Advancing Neurology with Technology and International Integration
This successful case exemplifies Vinmec's strategy to build centers of medical excellence through the integration of advanced technology, multidisciplinary expertise, and individualized treatment protocols. Vinmec has been ranked as the No.1 private hospital system in Vietnam for expatriates and international visitors, according to independent patient satisfaction surveys.
Vinmec Central Park is currently one of the few healthcare facilities in Vietnam, placing Vietnam among the few countries in Asia to master this technique—narrowing the gap with global neurology leaders.
(1) https://www.who.int/docs/default-source/mental-health/mhgap/epilepsy-and-seizures/epilepsy-q15.pdf
HO CHI MINH CITY, VIETNAM - Media OutReach Newswire - 29 July 2025 – A major breakthrough in Vietnam's neurological treatment was recently achieved as doctors at Vinmec Central Park International Hospital successfully performed surgery on a 9-year-old boy with drug-resistant epilepsy, utilizing the AutoGuide™ robotic Guidance system for SEEG implantation.This marks the first time in Vietnam that robotic guidance has been used in pediatric epilepsy surgery, — a milestone that opens new possibilities for safer, less invasive, and highly precise treatment options for vulnerable patients. The case also highlights Vietnam's progress in approaching global standards in advanced epilepsy care.The patient, B.Q.K. (age 9, from Hanoi), began experiencing seizures in 2021. Despite various treatment regimens and adjustments both domestically and abroad, his condition failed to improve - sometimes experiencing dozens of seizures per day.For nearly five years, his family sought treatment at numerous medical centers in the hope of giving their child a peaceful night's sleep without seizures.According to the World Health Organization (WHO), approximately 30% of epilepsy patients are drug-resistant, meaning they do not respond to medication. For these patients, surgery resection of the epileptic zone is often the most effective option. However, accurately localizing the epileptogenic zone - especially in children - is extremely challenging when scalp EEG, MRI, or PET scans provide inconclusive findings.Following a thorough multidisciplinary evaluation, doctors at Vinmec Central Park decided to use AutoGuide™ robotic navigation system to perform stereo-electroencephalography (SEEG) to accurately identify the epileptic zone. The robotic guidance ensured high accuracy, faster operative time, and reduced trauma to the brain.After seven days of SEEG monitoring, the epileptogenic zone was localized in the right orbitofrontal cortex and inferior frontal gyrus—areas densely packed with neural pathways and blood vessels. On June 17, 2025, the epileptic zone removal was performed by Dr. Truong Van Tri and his team at Vinmec Central Park, with technical support from Assoc. Prof. Dr. Shunsuke Nakae, an epilepsy specialist from Japan.The surgery was successful, with no postoperative neurological deficits. After more than one month of recovery, the patient resumed normal activities and play, with only two minor nocturnal seizures recorded - a reduction of over 95% compared to preoperative frequency.This successful case exemplifies Vinmec's strategy to build centers of medical excellence through the integration of advanced technology, multidisciplinary expertise, and individualized treatment protocols. Vinmec has been ranked as the No.1 private hospital system in Vietnam for expatriates and international visitors, according to independent patient satisfaction surveys.Vinmec Central Park is currently one of the few healthcare facilities in Vietnam, placing Vietnam among the few countries in Asia to master this technique—narrowing the gap with global neurology leaders.https://www.who.int/docs/default-source/mental-health/mhgap/epilepsy-and-seizures/epilepsy-q15.pdf
Hashtag: #Vinmec
The issuer is solely responsible for the content of this announcement.
About Vinmec Health System
Vinmec is a nonprofit healthcare system founded by Vingroup, one of Vietnam's largest private conglomerates. With 9 international hospitals and 4 international clinics nationwide, Vinmec is committed to delivering international-standard healthcare through subspecialized care, personalized treatment, and cutting-edge medical technology.
Vinmec Central Park in Ho Chi Minh City is the flagship hospital in the network and has been widely recognized as the top private hospital in Vietnam for expatriates and international patients, serving tens of thousands annually.
The hospital excels across several specialties:
Neurosurgery & Epilepsy: SEEG, robotic-guided surgery, brain tumor resection
Oncology – Orthopedic Surgery – Cardiology – Advanced Obstetrics & Gynecology
Allergy & Clinical Immunology: Vietnam's first and only center recognized as a Center of Excellence by the World Allergy Organization (WAO), in close partnership with Cleveland Clinic (USA) to develop precision medicine and chronic disease management programs
3D Medical Technology: Pioneer in 3D-printed titanium implants for complex orthopedic oncology reconstructions
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Barnama
31 minutes ago
- Barnama
WHO Moves 10 Trucks Of Medical Aid To Gaza Amid Soaring Health Needs
GENEVA, July 30 (Bernama-Anadolu) -- The World Health Organisation (WHO) has moved 10 trucks loaded with essential medical supplies in Gaza, Anadolu Ajansi (AA) reported, citing the organisation's chief. 'WHO has moved 10 trucks from Al-Arish in Egypt to the Kerem Shalom crossing for Gaza, carrying essential medicines, laboratory and water testing supplies,' Tedros Adhanom Ghebreyesus posted on X. He said more aid is on the way, noting that 'two additional trucks with medical supplies, along with 12 pallets of blood products, are expected tomorrow.' bootstrap slideshow All WHO aid will be transferred into Gaza, together with '3 trucks with medical supplies from health partners,' Tedros noted. 'The health needs in Gaza are immense,' he said, underlining that 'a continuous flow of medical supplies is critical.' Tedros once again called for unimpeded humanitarian access and a halt to hostilities: 'We continue to call for sustained, safe, and unhindered access for medical aid into and across Gaza and for a ceasefire.' Israel has maintained a blockade on Gaza for 18 years, and since March 2, it has sealed all border crossings, blocking the entry of humanitarian aid and worsening already dire conditions in the enclave. The Israeli army has pursued a brutal offensive on Gaza since Oct. 7, 2023, killing over 60,000 Palestinians. The relentless bombardment has devastated the enclave and led to food shortages. A total of 154 people, including 89 children, have died of starvation and malnutrition in Gaza since October 2023. On Monday, Israeli rights groups B'Tselem and Physicians for Human Rights-Israel accused Israel of committing genocide in Gaza, citing the systematic destruction of Palestinian society and the deliberate dismantling of the territory's healthcare system.
.jpg&w=3840&q=100)
Daily Express
12 hours ago
- Daily Express
GFN promotes tobacco harm reduction rationales to policy decision makers
Published on: Wednesday, July 30, 2025 Published on: Wed, Jul 30, 2025 By: David Thien Text Size: This year's GFN theme is 'Challenging Perceptions – Effective Communication for Tobacco Harm Reduction', gathered together global experts and stakeholders to forge strategic communication to reshape narratives and support evidence-based approaches to nicotine use and public health. WARSAW: The 12th edition of the Global Forum on Nicotine (GFN 2025) aims to get the right message to decision makers all around the world on the need to have alternative nicotine delivery products for those who could not give up nicotine use to curb smoking-related diseases and deaths. Experts agree that tobacco harm reduction can be a valuable public health strategy for reducing the negative impact of damaging behaviours in individuals who are unable or unwilling to quit smoking. Smoke-free products could reduce exposure to harmful chemicals. Meanwhile, the WHO's Framework Convention on Tobacco Control which was reported to be heavily funded by Michael Bloomberg, continues to promote a one-size-fits-all, abstinence-only model. The result has been restrictive bans on safer products while combustible cigarettes remain widely available. This year's GFN theme is 'Challenging Perceptions – Effective Communication for Tobacco Harm Reduction', gathered together global experts and stakeholders to forge strategic communication to reshape narratives and support evidence-based approaches to nicotine use and public health. The event was held from June 19 to 21, 2025, at the Presidential Hotel (formerly the Marriott) in the CBD heart of Warsaw, Poland to show how global tobacco and nicotine regulation discussions lack consumer representation, disadvantaging smokers and vapers. It was said that the World Conference on Tobacco Control overlooks harm reduction strategies, favouring prohibitionist policies influenced by figures like Michael Bloomberg and the World Health Organization (WHO). The upcoming COP11 and EU regulations could shape future nicotine policies, potentially blocking safer alternatives. Despite successful harm reduction examples in certain countries, for example, the EU is leaning towards restrictive measures like flavour bans and tax hikes. This should be challenged. Advocates emphasize the need for evidence-based, consumer-centric policies to combat smoking-related illnesses. Policymakers face a crucial decision: prioritize public health or maintain outdated ideologies at the expense of consumer well-being. UKM Prof. Dr Sharifa Ezat Wan Puteh, chair of the Malaysia Society for Harm Reduction and a panel speaker at GFN 2025 said: 'We can raise awareness in the community. We can train frontline staff in tobacco harm reduction. But if we don't have the safer nicotine products available, we are not achieving the change we need to achieve. 'In Malaysia, as well as in many other low and middle-income countries, tobacco control is very traditional. It's basically a prohibitionist approach which tries to ban everything under the sun, not only tobacco, but now also alternative nicotine products. 'Coming from an NGO, the Malaysian Society for Harm Reduction, we try to educate and advocate, but most of this falls on deaf ears. We are seen as arms of big tobacco, even though the research we produce is not funded by tobacco companies. 'I think there's a lot of failure stories, but there are a lot of success stories as well on the use of alternative nicotine products all over the world that low and middle-income countries can actually emulate, success stories like Japan, the UK or New Zealand,' said Prof. Dr Sharifa. The progress of tobacco harm reduction is being slowed by a paradox: as the scientific basis steadily consolidates, public perceptions are worsening by government's vilifying propaganda on alternative nicotine delivery products which are overlooked in smoking cessation protocols. At the GFN 2025 session on 'What I Hear vs. What I Know: Battling Misinformation from the Newsroom to the Facebook', panel speaker Maria Papaioannoy-Duic of Canada, said: 'What I've learned is when science doesn't back tobacco control's story, they don't revise the policy, they rewrite the story, not with facts, but with fear, drama and deliberate misinformation. 'In the fight for access to safer nicotine products, the truth isn't just ignored, it's attacked, silenced and mocked. A health official makes a statement, a journalist runs with it, a politician amplifies it, and suddenly it's viral. Meanwhile, we, consumers, advocates, we're in our chat groups, we are sharing sources, correcting headlines and trying to hold the line with science, evidence and facts.' According to Maria Papaioannoy-Duic, who is the founder and spokesperson of Rights 4 Vapers, the misinformation is institutional, not only in Canada, but around the world. Health agencies, regulators, even doctors, often repeat outdated or debunked information, sometimes out of fear, sometimes out of habit, and most times because they just don't have the time to learn. 'And the thing is, tobacco control knows this, and they capitalise on it. No one wants to really defend nicotine, because it's not sexy. But this isn't about being liked, it's about eradicating smoking, and that means telling the truth even when it's uncomfortable.' Maria Papaioannoy-Duic revealed that in 2022, the Canadian Tobacco and Nicotine Survey broke down the numbers on relative risk and beliefs among Canadians and found that 81 per cent of Canadians either misunderstood or had no idea that vaping is safer than smoking. 'And when we look at people who smoke, 79 per cent didn't know that vaping is safer, and among those who smoke but have never tried a vaping product, a staggering 90 per cent believed vaping is as bad or worse. 'These are the very people who stand to benefit the most from switching to safer alternatives, yet misinformation has left them stuck, misled, confused and still smoking. They truly believe, because of where they go to get their information, that smoking that cigarette will keep them alive longer and healthier than switching to a vape. 'My 2009 self would never believe what is happening in 2025. Millions of us who quit smoking with safer alternatives are now being told we're wrong. Instead of tobacco companies being the villains, it's us, people who use safer nicotine products and speak up and out about it, we are cast as the threats. 'Globally, governments are pushing their citizens to break the laws just to access a vape or pouch because the alternative to them is going back to smoking. When it comes to policy, science should take the lead, but in this space, emotion seems to win. Panic spreads faster than peer-reviewed studies. Tobacco Control is a well-oiled and frankly spoiled machine. It has no hesitation to reframe the narrative, to make anyone that goes against them the enemy, including folks who speak up for safer nicotine products. 'To them, we're the enemy, because we're telling the world nicotine isn't the problem, combustion is. So, what do we do? We continue to push back with facts, with strategy and with heart, and most importantly, with action, from rallies to letters, from bus tours to social media, from simple pop ups to emails, we find a way to tell our story. 'When you show up calmly with credible information and lived experience, that's when cracks start to form. When voices come together, when harm reduction meets medicine, meets policy, meets lived experience, that's when we get traction. So, whether you're an advocate, a policy maker, a health professional, someone trying to make a difference in your own circle, facts matter. Continue to share them, because lives depend on them. We are the public health heroes. We're the ones that have to push the narrative and we're the ones that have to keep moving forward,' Maria Papaioannoy-Duic stressed. * Follow us on our official WhatsApp channel and Telegram for breaking news alerts and key updates! * Do you have access to the Daily Express e-paper and online exclusive news? Check out subscription plans available. Stay up-to-date by following Daily Express's Telegram channel. Daily Express Malaysia
The Star
a day ago
- The Star
Pakistan to access free cancer medicines for 8,000 children annually from WHO
ISLAMABAD, July 29 (Xinhua) -- The World Health Organization (WHO) and Pakistan's Ministry of Health signed an agreement on Tuesday to formalize the country's participation in the Global Platform for Access to Childhood Cancer Medicines, aiming to provide quality-assured, free-of-cost medicines to children suffering from cancer. According to a statement from the WHO, the agreement would bring new hope to children battling cancer in Pakistan, with a goal to increase the survival rate from 30 percent to 60 percent by 2030. Limited access to treatment has been one of main factors behind the country's low childhood cancer survival rate, with over 8,000 new cases diagnosed annually, said the WHO. Pakistan became the second country in the Eastern Mediterranean Region to join the initiative, which was implemented in collaboration with the United Nations Children's Fund (UNICEF). UNICEF is responsible for procuring and delivering the medicines to the country. "WHO will also continue to support Pakistan's Ministry of Health and provincial authorities with the necessary technical expertise and logistical resources to combat childhood cancer," the statement added. Pakistan's Health Minister Mustafa Kamal called it a landmark achievement for the country's cancer-affected children, saying "If we are able to save even one life through this collaboration, we are saving mankind."
